Resr. Murat SERİLMEZ

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?

Yitgin Y., Erdem S., Serilmez M., Duranyıldız D., Verep S., Gasimov K., et al.

International Journal of Clinical Practice, vol.75, no.8, 2021 (SCI-Expanded)

Circulating annexin A2 as a biomarker in patients with pancreatic cancer.

Karabulut M., Afsar C. U., Serilmez M., Karabulut S.

Journal of cancer research and therapeutics, vol.16, 2020 (SCI-Expanded) Sustainable Development

Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma

Çavuş B., Akyuz F., İliaz R., Akyuz U., Duranyıldız D., Serilmez M., et al.

Experimental Oncology, vol.42, no.3, pp.208-214, 2020 (SCI-Expanded) Sustainable Development

Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?

Erturk K., Karaman S., Dagoglu N., Serilmez M., Duranyildiz D., Tas F.

WIENER KLINISCHE WOCHENSCHRIFT, vol.131, pp.419-426, 2019 (SCI-Expanded) Sustainable Development

The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer

Ucuncu M., Serilmez M., Sari M., Bademler S., Karabulut S.

BIOMOLECULES, vol.9, no.9, 2019 (SCI-Expanded) Sustainable Development

Serum IL-17 levels can be diagnostic for gastric cancer.

Karabulut M., Afsar C. U., Serimez M., Karabulut S.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.24, no.4, pp.1601-1609, 2019 (SCI-Expanded) Sustainable Development

Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer

Bademler S., Ucuncu M. Z., Yasasever C., Serilmez M., Ertin H., Karanlik H.

BIOMOLECULES, vol.9, no.3, 2019 (SCI-Expanded) Sustainable Development

Serum IL-17 levels can be diagnostic for gastric cancer

Karabulut M., Usul Afşar Ç., Serilmez M., Karabulut S.

Journal Of Buon, vol.24, no.4, pp.1-9, 2019 (SCI-Expanded)

Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy

Serilmez M., Ozgur E., Karaman S., Gezer U., Duranyildiz D.

CANCER BIOMARKERS, vol.25, no.2, pp.177-184, 2019 (SCI-Expanded) Sustainable Development

SERUM AKT2 LEVELS AS A MARKER FOR LUNG CANCER

Karaman S., Erturk K., Serilmez M., Duranyilidiz D., Oral E. N., Dagoglu N.

ACTA MEDICA MEDITERRANEA, vol.35, no.6, pp.3269-3272, 2019 (SCI-Expanded) Sustainable Development

Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer

Afsar C. U., Karabulut M., Karabulut S., Ozal S. T., Cikot M., Serilmez M., et al.

BIOMOLECULES, vol.8, no.4, 2018 (SCI-Expanded) Sustainable Development

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer

BADEMLER S., Sari M., Üçüncü M. Z., SERİLMEZ M., Karabulut S.

Acta Medica Mediterranea, vol.34, no.6, pp.2055-2060, 2018 (SCI-Expanded) Sustainable Development

Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients

Erturk K., Tas F., Serılmez M., Bilgin E., Yasasever V.

Asian Pacific journal of cancer prevention : APJCP, vol.18, pp.1383-1387, 2017 (SCI-Expanded)

Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma

Afsar C. U., Karabulut M., Karabulut S., Alis H., Gonenc M., Dagoglu N., et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY, vol.23, pp.196-200, 2017 (SCI-Expanded)

Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma

Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.

Arab Journal of Gastroenterology, vol.17, no.4, pp.164-167, 2016 (SCI-Expanded)

Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients

Guveli M. E., Duranyildiz D., Karadeniz A., Bilgin E., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY, vol.37, no.7, pp.8979-8983, 2016 (SCI-Expanded) Sustainable Development

Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.

KARABULUT M., GUNALDI M., ALIS H., AFSAR C., KARABULUT S., Serilmez M., et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol.18, pp.160-71, 2016 (SCI-Expanded)

Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.

BIOMEDICINE & PHARMACOTHERAPY, vol.77, pp.86-91, 2016 (SCI-Expanded) Sustainable Development

Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer

Tas F., Karabulut S., Serilmez M., KARABULUT M., Duranyildiz D.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.77, no.1, pp.127-131, 2016 (SCI-Expanded) Sustainable Development

Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.

TUMOR BIOLOGY, vol.37, no.1, pp.405-412, 2016 (SCI-Expanded) Sustainable Development

CLINICAL SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR (HGF) AND ITS RECEPTOR CMET LEVELS IN COLORECTAL CANCER PATIENTS

KARABULUT M., ALIS H., GUNALDI M., AFSAR C. U., Karabulut S., KONES O., et al.

ACTA MEDICA MEDITERRANEA, vol.32, no.1, pp.179-187, 2016 (SCI-Expanded) Sustainable Development

Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma

Sen F., Yildiz I., Odabas H., Tambas M., Kilic L., Karadeniz A., et al.

TUMOR BIOLOGY, vol.36, pp.1039-1044, 2015 (SCI-Expanded) Sustainable Development

D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.

Kilic L., Yildiz I., Sen F. K., ERDEM M. G., Serilmez M., Keskin S., et al.

Cancer biomarkers : section A of Disease markers, vol.15, no.4, pp.405-11, 2015 (SCI-Expanded) Sustainable Development

The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY, vol.35, no.9, pp.8849-8860, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.

TUMOR BIOLOGY, vol.35, no.7, pp.6619-6625, 2014 (SCI-Expanded) Sustainable Development

Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY, vol.35, no.4, pp.3327-3331, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY, vol.35, no.4, pp.3125-3132, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY, vol.35, no.4, pp.3611-3616, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY, vol.35, no.4, pp.3095-3102, 2014 (SCI-Expanded) Sustainable Development

Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.73, no.3, pp.631-637, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY, vol.35, no.3, pp.2327-2333, 2014 (SCI-Expanded)

Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.

TUMOR BIOLOGY, vol.35, no.3, pp.2729-2739, 2014 (SCI-Expanded)

Clinical significance of serum M30 and M65 levels in melanoma

Tas F., Karabulut S., Serilmez M., Yildiz I., Sen F., Ciftci R., et al.

MELANOMA RESEARCH, vol.23, no.5, pp.390-395, 2013 (SCI-Expanded)

Clinical and prognostic significance of coagulation assays in gastric cancer.

Tas F., Ciftci R., Kilic L., Serilmez M., Karabulut S., Duranyildiz D.

Journal of gastrointestinal cancer, vol.44, pp.285-92, 2013 (SCI-Expanded) Sustainable Development

A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

Yildiz I., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.72, no.2, pp.437-444, 2013 (SCI-Expanded) Sustainable Development

Clinical and prognostic significance of coagulation assays in lung cancer

Tas F., Kilic L., Serilmez M., Keskin S., Sen F., Duranyildiz D.

RESPIRATORY MEDICINE, vol.107, no.3, pp.451-457, 2013 (SCI-Expanded) Sustainable Development

For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?

Bilgin E., Dizdar Y., Serilmez M., Soydinc H. O., Yasasever C., Duranyildiz D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.4, pp.2541-2544, 2013 (SCI-Expanded) Sustainable Development

Immobilization and stabilization of alpha-galactosidase on Sepabeads EC-EA and EC-HA

Bayraktar H., Serilmez M., Karkas T., Celem E. B., ÖNAL S.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, vol.49, no.4, pp.855-860, 2011 (SCI-Expanded)

Hematological parameters in lung cancer Akciǧer kanserinde hematolojik parametreler

SERİLMEZ M., Oǧuz H. O., ÇAMLICA H., TOPUZ E., DURANYILDIZ D.

Turk Onkoloji Dergisi, vol.25, no.3, pp.87-92, 2010 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals

Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer

Ak N., Serilmez M., Ucuncu M. Z., Bademler S., Vatansever S.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.36, no.2, pp.165-170, 2021 (ESCI) Sustainable Development

Serum Glypican-3, Vascular Endothelial Growth Factor, and lnterleukin-6 Levels in Hepatocellular Carcinoma

Serilmez M., Akyuz F., Ormeci Ciftcibasi A., Karabulut S., Kaymakoglu S., Yasasever V., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.33, no.1, pp.18-27, 2018 (ESCI)

Significance of serum neural precursor cell-expressed developmentally downregulated protein 9 in melanoma

Erturk K., Tas F., Serılmez M., Bilgin E., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY, vol.8, no.1, pp.204-208, 2018 (ESCI)

Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma

Karabulut S., Afsar C. U., Karabulut M., Alis H., Bozkurt M. A., Aydogan F., et al.

BBA CLINICAL, vol.6, pp.138-142, 2016 (ESCI) Sustainable Development

Is serum tenascin-C level potential biomarker in pancreatic adenocarcinoma?

Karabulut S., KARABULUT M., ALIS H., Tambas M., KAPAN S., KONES O., et al.

MEDICAL JOURNAL OF BAKIRKOY, vol.12, no.2, pp.76-82, 2016 (ESCI)

Akciğer Kanserinde Hematolojik Parametreler

SERİLMEZ M., OĞUZ SOYDİNÇ H., CAMLICA H., TOPUZ E., DURANYILDIZ D.

TÜRK ONKOLOJİ DERGİSİ, vol.25, no.3, pp.87-92, 2010 (Scopus) Sustainable Development

Hematological parameters in lung cancer

SERİLMEZ M., OĞUZ SOYDİNÇ H., Camlica H., Topuz E., DURANYILDIZ H. D.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.25, no.3, pp.87-92, 2010 (ESCI) Sustainable Development

Refereed Congress / Symposium Publications in Proceedings

Tensin-2 Molekülünün Meme Kanserli Hastalardaki Önemi

YASASEVER C. T., BILGIN E., SERİLMEZ M., OĞUZ SOYDİNÇ H., BADEMLER S., KARANLIK H., et al.

29. Ulusal Biyokimya Kongresi, Muğla, Turkey, 26 - 30 October 2018, pp.1 Sustainable Development

Importance of AXL Molecule in Lung Cancers

Kizir A., Bilgin Doğru E., Tilgen Yasasever C., Serilmez M.

15. İstanbul Üniversitesi Onkoloji Enstitüsü Günleri Sempozyumu ve 8. İstanbul Üniversitesi Onkoloji Enstitüsü Çalıştayı, İstanbul, Turkey, 1 - 02 December 2017, pp.1

Over Kanserinde HMGB1 ve IRE1'in Önemi

BİLGİN DOĞRU E., TİLGEN YASASEVER C., SERİLMEZ M., SAİP P. M., YASASEVER F. V.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.159 Sustainable Development

Meme Kanserli Hastalarda TIMP-1, HA ve SPARC Düzeyleri

Tilgen Yasasever C., Bilgin Doğru E., Serilmez M., Öztürk N., Yasasever F. V.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.162 Sustainable Development

Clinical significance of serum cmet and hgf protein and mRNA levels in lung cancer.

SERİLMEZ M., ÖZGÜR E., KARAMAN Ş., OĞUZ SOYDİNÇ H., DURANYILDIZ D., YASASEVER V.

41st Congress of the Federation of European Biochemical Societies (FEBS), İzmir, Turkey, 3 - 08 September 2016, pp.1 Sustainable Development

Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.

3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Turkey, 11 - 15 May 2016, pp.1 Sustainable Development

Over Kanserli Hastalarda Prolaktin ve Interlökin-10’un Rolü”

SERİLMEZ M., OĞUZ SOYDİNÇ H., KURU O., DURANYILDIZ D., YASASEVER V.

6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1 Sustainable Development

Meme Kanserli Hastalarda NGAL ve MMP-9'un Kemoterapi İle Değişimi

OĞUZ SOYDİNÇ H., SERİLMEZ M., ŞEN F., DURANYILDIZ D., YASASEVER V.

6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.1 Sustainable Development

Hepatosellüler karsinomda galektin-3 ve fibronektin molekülleri yeni bir tümör belirteci olabilir mi?

SERİLMEZ M., AKYÜZ M., TAŞTEKİN D., OĞUZ SOYDİNÇ H., DURANYILDIZ D.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.1

Meme kanserli hastalarda plazma D-Dimer düzeylerinin tümör yükü ve metastazı ile ilişkisi

KILIC L., ŞEN F., YILDIZ İ., KESKİN S., EKENEL M., SERİLMEZ M., et al.

4. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2012, pp.250 Sustainable Development

What kind of a role may play IFN-gamma and emmprin in head and neck cancers?

Bilgin E., Serilmez M., Duranyildiz D., Yasasever V.

36th FEBS Congress of the Biochemistry for Tomorrows Medicine, Torino, Italy, 25 - 30 June 2011, vol.278, pp.197 Sustainable Development

Angiogenesis markers in nasopharynx and larynx cancers

Serilmez M., Bilgin E., Yasasever V., Duranyildiz D.

36th FEBS Congress of the Biochemistry for Tomorrows Medicine, Torino, Italy, 25 - 30 June 2011, vol.278, pp.233 Sustainable Development

Baş-Boyun kanserlerinde VEGF-C’nin yeri var mı?

Serilmez M., BİLGİN E., KARADENİZ A. N., Yildiz I., YASASEVER F. V.

19. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1 Sustainable Development

Kolon ve rektum karsinomlu hastalarda EGFR IL-6 ve IL-10 düzeyleri

SERİLMEZ M., OĞUZ SOYDİNÇ H., KILIÇ L., UZUNOĞLU S., TAŞ F., DURANYILDIZ D.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1

Mide karsinomlarında sitokin ve epidermal büyüme faktörü (EGFR) düzeyleri

SERİLMEZ M., OĞUZ SOYDİNÇ H., CICIN I., UZUNOĞLU S., DURANYILDIZ D.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.1

The levels of plasma fibrinogen in cancer patients

SERİLMEZ M., OĞUZ SOYDİNÇ H., DURANYILDIZ D.

The 5th APOCP Conference, İstanbul, Turkey, 3 - 07 April 2010, pp.1 Sustainable Development

Renal function tests in childhood cancer

OĞUZ SOYDİNÇ H., SERİLMEZ M., YASASEVER V.

The 5th APOCP Conference, İstanbul, Turkey, 3 - 07 April 2010, pp.1 Sustainable Development

Platin-bazlı kemoterapi alan hastalarda üre- kreatinin değerleri

OĞUZ SOYDİNÇ H., SERİLMEZ M., TAŞ F., YASASEVER V.

21. Ulusal Biokimya Kongresi, İstanbul, Turkey, 28 - 31 October 2009, pp.1

Akciğer kanserli hastalarda kemoterapi ve radyoterapinin hematolojik parametreler üzerine etkisi

SERİLMEZ M., OĞUZ SOYDİNÇ H., TAŞ F., DURANYILDIZ D.

21. Ulusal Biokimya Kongresi, İstanbul, Turkey, 28 - 31 October 2009, pp.1 Sustainable Development

Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings